AiCure

Archives

Choose a date range

From To

Choose one or more categories

Categories:



Show only original CenterWatch stories

 


Altasciences expands to U.S., launches Algorithme Pharma USA

Thursday, November 20, 2014 01:36 PM

Altasciences has opened Algorithme Pharma USA, further expanding the company’s North American footprint and ability to provide comprehensive bioequivalence and phase I/IIa clinical drug development capabilities in the U.S.

More... »


Omeros reports positive data for OMS721 for thrombotic microangiopathy

Thursday, November 20, 2014 01:29 PM

Omeros has announced positive data using OMS721, the lead human monoclonal antibody for its mannan-binding lectin-associated serine protease-2 (MASP-2) program, to inhibit thrombus formation in an ex vivo pathophysiologic system of human atypical hemolytic uremic syndrome (aHUS), a form of thrombotic microangiopathy (TMA).

More... »


BerGenBio receives Orphan Drug designation from FDA for AML treatment

Thursday, November 20, 2014 01:25 PM

The FDA has granted Orphan Drug designation for BerGenBio’s BGB324 for treatment of acute myeloid leukaemia (AML).

More... »

Spinal muscular atrophy program enters phase Ib/IIa trial in patients with SMA

Thursday, November 20, 2014 01:19 PM

PTC Therapeutics’ joint development program in spinal muscular atrophy (SMA) with Roche and the SMA Foundation (SMAF) has started a phase Ib/IIa study in adult and pediatric patients. The placebo-controlled, randomized, multiple-dose study will enroll approximately 48 patients with SMA and investigate the safety and tolerability of an investigational survival of motor neuron 2 (SMN2) gene splicing modifier (RG7800) over 12 weeks. The achievement of this milestone triggers a $10 million payment to PTC from Roche.

More... »

Icon Firecrest receives global award for healthcare training animation

Thursday, November 20, 2014 12:50 PM

Icon Firecrest, a provider of integrated Web-based services that optimize clinical trial performance, received a 2014 Global Award for its art and technique: animation entry, “Firecrest Through the Body.” This 3D animated video was created and developed by a team of 3D graphic designers and pharmacologists at Firecrest.

More... »

PPD’s Randy Anderson named Health Care Hero for diabetes research

Thursday, November 20, 2014 12:49 PM

Randy Anderson, Ph.D., vice president of global product development and therapeutic area leader for metabolics at global CRO Pharmaceutical Product Development (PPD), was named a 2014 Health Care Hero. The annual awards honor members of the greater Wilmington medical community for their engagement on critical health issues.

More... »

Vermillion forms new strategic and medical advisory board

Thursday, November 20, 2014 12:43 PM

Vermillion, a bio-analytical solutions company focused on gynecologic disease, recently outlined its expanded strategy for driving improvements in the personalized management of gynecologic health and becoming a leading diagnostic innovator in gynecologic informatics. In support of this mission, the company has named three charter members of its strategic and medical advisory board.

More... »

Amgen, Novartis partner with Atlas Venture

Wednesday, November 19, 2014 02:37 PM

Atlas Venture, based in Cambridge, Mass., has entered into corporate strategic partnership (CSP) agreements with both Amgen, through its venture capital fund, Amgen Ventures, and Novartis. Atlas IX is expected to create and/or fund more than 15 new biotech companies and anticipates these new CSP relationships will be integral parts of facilitating their launch and progression.    

More... »

Certara updates Simcyp Simulator

Wednesday, November 19, 2014 02:36 PM

Certara, a Princeton, N.J.-based global technology-enabled drug development and drug safety consultancy, has released version 14 of its Simcyp Population-based Simulator, which enables biopharmaceutical researchers to predict drug-drug interactions and pharmacokinetic-pharmacodynamic (PK-PD) outcomes in virtual human and animal populations.

More... »

Genomics England calls on the U.K. research community

Wednesday, November 19, 2014 02:25 PM

Genomics England is inviting applications to join a new Clinical Interpretation Partnership from U.K. researchers, NHS Clinicians and those in training where they will work on the unique data resource from the 100,000 Genomes Project. The goal of the Genomics England Clinical Interpretation Partnership (GeCIP) is to bring together the best researchers in the U.K., alongside their key international collaborators, to ensure maximized potential to gaining new biological insights into rare inherited diseases, cancers and infectious disease.

More... »

CenterWatch Drugs in Clinical Trials
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

November 24

Tufts CSDD’s $2.6 billion price tag to develop and bring a new drug to market raises questions, criticisms

Medidata joins GlaxoSmithKline in study to evaluate the impact of wearing mobile devices in clinical trials

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

October

CROs driving changes in patient recruitment
Data- and tech-aided enrollment services a competitive advantage

Trials with in-home nurses poised to grow
Higher expense, but may improve recruitment and retention for select trials

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs